CHA sent a letter to the DEA supporting their policy change to better address children’s unique health care needs. CHA has advocated that the DEA maintain access to care for children via telehealth and reiterated our support for the special registration process in our letter. The DEA will have another comment period this fall before the telemedicine rules are finalized.
CHA Sends Letter to DEA on Tele-prescribing for Controlled Substances
Related Content
Creating a Universal Standard for Lab Test Names
A multidisciplinary collaborative works to eliminate confusion, errors, and waste from the laboratory test ordering process.
CHA Response to Drug Shortages White Paper
CHA submitted comments on a drug shortages white paper to highlight pediatric health care needs.
5 Reasons to Start a Specialty Pharmacy
For many children’s hospitals and health systems, the benefits of an internal specialty pharmacy outweigh the costs.